HOME >> BIOLOGY >> NEWS
Millennium Clones Diet-Induced Obesity Gene

CAMBRIDGE, Mass. March 11, 1999 -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) has cloned the first gene that can suppress diet-induced obesity in mice. The gene may have strong implications in developing therapies to intervene in human obesity, the authors note in their report, which appears in the March 11, 1999 issue of Nature.

The scientists found that while the gene, called mahogany (mg), produces a protein (MG) in many tissues of the body, its activity in a specific region of the brain's hypothalamus is particularly interesting because of that region's role in body weight regulation.

"The cloning of the mahogany gene and the identification of its protein product are major first steps in achieving a better understanding of their roles in controlling weight based on the amount of fat in a diet," said Karen Moore, Ph.D., director of genetic systems at Millennium. Because of the great similarity between mouse and human metabolism, the scientists expect to find that the gene plays a similar role in people.

Mice with a mutation in their mg gene maintain a healthy weight whether they eat a high fat (42 percent fat) or low fat (9 percent fat) diet with the same amount of calories. In contrast, mice with a normal mg gene gain excess weight on the high fat diet. Such diet-induced obesity differs from forms of genetically-induced obesity in which weight gain occurs even when mice are fed a normal diet. Genetically induced obesity in mice has been linked to mutations in the obese (ob), diabetes (db), tubby (tub), fat (fat) and agouti-yellow (Ay) genes. Mice with a mutation in their mg gene can suppress the genetic induced obesity of agouti-yellow mice but not that of ob, db, tub and fat mice.

The structure of the large MG protein is complex and can occur in two major forms. One form spans the cell wall leaving multiple sections of the protein to project outside the cell, which may function as receptors to which small proteins called peptide
'"/>

Contact: Marion E. Glick
m.glick@noonanrusso.com
212-696-4455 x221
Noonan/Russo Communications
11-Mar-1999


Page: 1 2 3 4

Related biology news :

1. Millenniums LDP(PS)-341 inhibits growth and induces death of cancer cells, appears to overcome chemotherapy resistance
2. Millennium and Bayer industrializing drug discovery process through ongoing successful research alliance
3. Science and Technology at the Millennium: Retrospect or Prospect Focus of AAAS Science and Technology Colloquium, April 11-13 in Washington, DC
4. Millennium and Wyeth-Ayerst announce the discovery of key potassium ion channel modulating proteins
5. Millennium and the Whitehead Institute identify novel protein important in fat absorption
6. Allelix Clones Receptor For Intestinal Growth Factor GLP-2
7. International Research Team Clones New Skin Cancer Gene
8. Obesity and hypertension: Two epidemics or one?
9. Obesity alone not a good predictor of cardiovascular risk and death, fat distribution proved best
10. Obesity drug inhibits prostate tumor growth
11. Obesity and blood pressure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... , April 5, 2017 Today ... announcing that the server component of the HYPR platform ... for providing the end-to-end security architecture that empowers biometric ... HYPR has already secured over 15 million users ... including manufacturers of connected home product suites and physical ...
(Date:3/30/2017)... The research team of The Hong Kong ... identification by adopting ground breaking 3D fingerprint minutiae recovery and matching ... and accuracy for use in identification, crime investigation, immigration control, security ... ... A research team led by ...
(Date:3/24/2017)... , March 24, 2017 The Controller General of ... Mr. Abdulla Algeen have received the prestigious international IAIR Award ... Continue Reading ... ... and Deputy Controller Abdulla Algeen (small picture on the right) have received ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... San Diego, CA (PRWEB) , ... ... ... BioInformatics (https://www.onramp.bio/ ) has launched Rosalind™, the first-ever genomics analysis platform ... eliminating all bioinformatics complexity. Named in honor of pioneering researcher Rosalind Franklin, ...
(Date:10/11/2017)... ... 11, 2017 , ... The CRISPR-Cas9 system has ... and avoiding the use of exogenous expression plasmids. The simplicity of programming this ... gain-of-function studies. , This complement to loss-of-function studies, such as with RNAi ...
(Date:10/11/2017)... USA (PRWEB) , ... October 11, 2017 , ... ComplianceOnline’s ... take place on 7th and 8th June 2018 in San Francisco, CA. The Summit ... as well as several distinguished CEOs, board directors and government officials from around the ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
Breaking Biology Technology:
Cached News: